Senior Vice
Equibles does not estimate personal net worth.
Get an email with a short summary when Eledon Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELDN alertsAbout Senior Vice
The proxy statement of Eledon Pharmaceuticals, Inc. reports total compensation of $392,850 for Senior Vice in fiscal 2019, including a base salary of $295,722. Disclosed compensation is on record for 2 fiscal years. Eledon Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eledon Pharmaceuticals, Inc. includes David-Alexandre "DA" C. Gros, M.D. (CEO and Board Member), David-Alexandre C. Gros (CEO and Board Member), David-Alexandre C. Gros, M.D. (CEO and Board Member) and 7 others.
Affiliation history
-
Eledon Pharmaceuticals, Inc. (ELDN)
Proxy statement
Current
Company network
Leadership on record at Eledon Pharmaceuticals, Inc.
- David-Alexandre "DA" C. Gros, M.D. CEO, Board Member
- David-Alexandre C. Gros CEO, Board Member
- David-Alexandre C. Gros, M.D. CEO, Board Member
- David-Alexandre Gros CEO, Board Member
- Jon Kuwahara CEO
- Paul Little CFO, Chief Accounting Officer
- Bryan Smith General Counsel
- Allan D. Kirk Board Member
- Allan Douglas Kirk, MD, PhD, FACS Board Member
- James Robinson Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Eledon Pharmaceuticals, Inc. (ELDN) | President of Finance and Administration | $295,722 | $392,850 |
| 2018 | Eledon Pharmaceuticals, Inc. (ELDN) | President of Finance and Administration | $281,065 | $429,581 |
Recent activity
No call appearances or filed executive changes recorded yet.